The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil.
 
Peter Grell
Honoraria - BMS GmbH & Co. KG; Merck KGaA; Roche
Travel, Accommodations, Expenses - Roche; SERVIER
 
Stanislav Batko
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Ipsen; Lilly; Merck; Pierre Fabre; SERVIER
 
Alina Pirsthuk
No Relationships to Disclose
 
Simona Borilova
No Relationships to Disclose
 
Katerina Polachova
No Relationships to Disclose
 
Blanka Mazuchova
No Relationships to Disclose
 
Jiri Tomasek
No Relationships to Disclose
 
Pavel Fabian
No Relationships to Disclose
 
Jitka Berkovcova
No Relationships to Disclose
 
Miroslav Bardelcik
No Relationships to Disclose
 
Radka Obermannova
Honoraria - BMS GmbH & Co. KG; Merck KGaA
Travel, Accommodations, Expenses - SERVIER
 
Tomas Buchler
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; Janssen; Sanofi/Aventis
Speakers' Bureau - Accord Healthcare; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; SERVIER
Research Funding - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck KGaA; MSD; Novartis; Roche
 
Igor Kiss
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; MSD Oncology
Speakers' Bureau - BMS; Merck; Merck; MSD Oncology; Pierre Fabre Médicament; SERVIER; Servier